Abstract
Seven fluorinated derivatives of diethyl-2-(benzylthio)-2,3-dihydro-1H-imidazole-4,5-dicarboxylate (a–g) as well as a nitro and chloro derivative (h–i) were prepared in five steps from glycine, ethyl formate, diethyl oxalate, potassium thiocyanate and substituted benzyl bromides. The structures of the synthesised compounds were elucidated and verified using 1H, 13C and 2D NMR spectroscopy where appropriate. The synthesised compounds exhibited concentration dependent antiplatelet aggregation activity on both the thrombin and ADP-induced platelet aggregation. The 4-nitro and 4-fluoro compounds exhibited the highest activity from the compounds tested, with IC50 values of 1.06 and 1.20 mM for the thrombin-induced assay and 18.57 and 12.91 mM in the ADP-induced platelet aggregation assay respectively. Three of the compounds, the 3′′,4′′-difluoro (6c), 4′′-nitro (6h) and 3′′-chloro (6i) derivatives, have reasonable activity in both of the assays and could have potential as broad spectrum antiplatelet inhibitors. With the exception of 6c, the fluoro derivatives were not as active as the nitro and chloro compounds.
Similar content being viewed by others
References
Anderson WK, Bhattacharjee D, Houston DM (1989) Design, synthesis, antineoplastic activity and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethy1)imidazole. J Med Chem 32:119–127
Bagrii AK, Vasilenko TE (1978) Study of the cyanethylation of aryl derivatives of 2-thioimidazole. Farm Zh (Kiev) 4:33–36
Ballabeni M, Ballini R, Bigi F, Maggi R, Parrini M, Predieri G, Sartori G (1999) Synthesis of symmetrical N,N′-disubstituted thioureas and heterocyclic thiones from amines and CS2 over a ZnO/Al2O3 composite as heterogeneous and reusable catalyst. J Org Chem 64:1029–1032
Bhatnagar A, Sharma PK, Kumar N (2011) A review on “Imidazoles”: their chemistry and pharmacological potentials. Int J PharmTech Res 3:268–282
Billheimer JT, Gillies PJ, Wilkerson WW (1990) Anti hypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles. US Patent 4900744
Boldron C, Besse A, Bordes M-F et al (2014) N-[6-(4-Butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist. J Med Chem 57:7293–7316
Buhler S, Goettert M, Schollmeyer D, Albrecht W, Laufer SA (2011) Chiral sulfoxides as metabolites of 2-thioimidazole-based p38α mitogen-activated protein kinase inhibitors: enantioselective synthesis and biological evaluation. J Med Chem 54:3283–3297
Caroff E, Meyer E, Treiber A, Hilpert K, Riederer MA (2014) Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 24:4323–4331
Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482–2494
Dawood KM, Wahab-Abdel BF (2010) Synthesis, reactions, and biological activity of 4,5-diarylimidazole-2-thiones (Review). Chem Heterocycl Compd 46:255–278
Doerge DR, Decker CJ, Takazawall RS (1993) Chemical and enzymatic oxidation of benzimidazoline-2-thiones: a dichotomy in the mechanism of peroxidase inhibition. Biochemistry 32:58–65
Fabre J, Gurney ME (2010) Limitations of current therapies to prevent thrombosis: a need for novel strategies. Mol BioSyst 6:305–315
Giordanetto F, Barlaam B, Berglund S, Edman K, Karlsson O, Lindberg J, Nylander S, Inghardt T (2014) Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents. Bioorg Med Chem Lett 24:3936–3943
Harris LF, Killard AJ (2014) Moving away from heparin: the new antithrombotic and antiplatelet drugs. In: Wlkinson NB (ed) Heparin. Nova Science Publishers, New York, pp 21–39
Hayashi M, Yokomori S, Hatayama K, Kaoru S (1989) Preparation of pyridylmethylthio- and methylsulfinyl imidazole derivatives as platelet aggregation inhibitors. Jpn Kokai Tokkyo Koho JP 62187469
Hozien ZA, El-Wareth AOSA, El-Sherief HAH, Mahmoud AM (2000) An efficient route for synthesis of 5,6-diphenylimidazo-[2,1-b]thiazoles as antibacterial agents. J Heterocycl Chem 37:943–949
Imbalzano E, Creazzo M, Trapani G, Stellitano A, Zucco M, Quartuccio S, Lizio G, Dattilo G, Saitta A (2014) Heparin: which molecule? What Clinical applications? In: Wilkinson NB (ed) Heparin. Nova Science Publishers, New York, pp 1–20
Iradyan MA, Ayvazyan AKh, Mirzoyan VS, Paronikyan GM, Sarkisyan TP, Stepanyan GM, Arsenyan FG, Garibdzhanyan BT (1987) Imidazole derivatives. XIX. Synthesis and biological activity of 4-nitro-5-thioimidazole derivatives. Pharm Chem J 21:403–408
Jones RG (1952) Studies on imidazoles. VI. Synthesis of 4,5-imidazoledicarboxylates. J Am Chem Soc 74:1085–1086
Lagoja IM, Pannecouque C, van Aerschot A, Witvrouw M, Debyser Z, Balzarini J, Herdewijn P, de Clercq E (2003) N-Aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action. J Med Chem 46:1546–1553
Maduskuie TP, Wilde RG, Billheimer JT, Cromley DA, Germain S, Gillies PJ, Higley A, Johnson AL, Pennev P, Shimshick EJ, Wexler RR (1995) Design, synthesis, and structure-activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. J Med Chem 38:1067–1083
Makita A, Isobe Y, Tomizawa H, Chiba S, Sasaki M (2000) Preparation of 3-nitrogen-containing 5-membered heterocyclylthio-1,2-propanediols and cytosolic phospholipase A2 inhibitors. Jpn Kokai Tokkyo Koho JP 2000038380
Mekhfi H, El Haouari M, Legssyer A, Bnouham M, Aziz M, Atmani F, Remmal A, Ziyyat A (2004) Platelet anti-aggregant property of some Moroccan medicinal plants. J Ethnopharmacol 94:317–322
Mosa RA, Oyedeji AO, Shode FO, Singh M, Opoku AR (2011) Triterpenes from the stem bark of Protorhus longifolia exhibit anti-platelet aggregation activity. Afr J Pharm Pharmacol 5:2698–2714
Muccioli GG, Fazio N, Scriba GKE, Poppitz W, Cannata F, Poupaert JH, Wouters J, Lambert DM (2006) Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates. J Med Chem 49:417–425
Parekh PJ, Merrell J, Brush JE, Johnson DA (2014) Clinical review: pharmacology of traditional and modern anticoagulant and antiplatelet therapy. In: Alesci JP, Victorino A (eds) Clopidogrel. Nova Science Publishers, New York, pp 1–52
Saeed A, Batool M (2007) Synthesis and bioactivity of some new 1-tolyl-3-aryl-4-methylimidazole-2-thiones. Med Chem Res 16:143–154
Savjani JK, Gajjar AK (2011) Pharmaceutical importance and synthetic strategies for imidazolidine-2-thione and imidazole-2-thione derivatives. Pak J Biol Sci 14:1076–1089
Selig R, Schattel V, Goettert M, Schollmeyer D, Albrecht W, Laufer S (2011) Conformational effects on potency of thioimidazoles and dihydrothiazolines. Med Chem Commun 2:261–269
Sharpe TR, Cherkofsky SC, Hewes WE, Smith DH, Gregory WA, Haber SB, Leadbetter MR, Whitney JG (1985) Preparation and antiarthritic and analgesic activity of 4,5-diaryl-2-(substituted thio)-1H-imidazoles and their sulfoxides and sulfones. J Med Chem 28:1188–1194
Skvortsova GG, Abramova ND, Trzhtsinskaya BV (1974) Synthesis and some properties of N,S-divinyl-2-mercaptobenzimidazole. Chem Heterocycl Compd 10:1217–1220
Tang J, Fang Y, Han Y, Bai X, Yan X, Zhang Y, Lai R, Zhang Z (2014) YY-39, a tick anti-thrombosis peptide containing RGD domain. Peptides. doi:10.1016/j.peptides.2014.08.008
Tomita T, Umegaki K, Hayashi E (1983) Basic aggregation properties of washed rat platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation. J Pharmacol Methods 10:31–44
Trzhtsinskaya BV, Abramova ND (1991) Imidazole-2-thiones: synthesis, structure, properties. Sulfur Reports 10:389–430
Trzhtsinskaya BV, Aleksandrova AE, Abramova ND, Andriyankova LV, Vinogradova TI, Shchegoleva RA (1992) Synthesis and tuberculostatic activity of imidazole-2-thione derivatives. Khim-Farm Zh 4:57–60
Tsuji M, Inoue T, Ikesue K, Fujimoto N, Noda K (1989) Preparation of (heterocyclylalkylthio-or-sulfinyl)diphenylimidazoles as antiulcer and antiinflammatory agents. Jpn Kokai Tokkyo Koho JP 01040467
Yasser ML, El-Badawi MA, El-Barbary AA, Pedersen EB, Nielsen C (2003) Synthesis of 2-methylsulfanyl-1H-imidazoles as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs). Arch Pharm 336:175–180
Zhang H, Hollenberg PF (2014) From mechanism to therapeutics: overcoming inter-individual variability in clopidogrel therapy. In: Alesci JP, Victorino A (eds) Clopidogrel. Nova Science Publishers, New York, pp 121–147
Acknowledgments
This research was supported by grants from the National Research Foundation (NRF), South Africa and was supported by the South African Research Chairs Initiative of the Department of Science and Technology. We thank Dr Hong Su from the University of Cape Town for X-Ray analysis.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Momin, M.I.K., Ramjugernath, D., Mosa, R.A. et al. Synthesis and in vitro antiplatelet aggregation screening of novel fluorinated diethyl-2-(benzylthio)-2,3-dihydro-1H-imidazole-4,5-dicarboxylate derivatives. Med Chem Res 24, 2075–2084 (2015). https://doi.org/10.1007/s00044-014-1284-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1284-6